Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity
- PMID: 26799377
- PMCID: PMC5706464
- DOI: 10.1021/acs.biochem.5b01168
Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity
Abstract
Protein misfolding results in the accumulation of aggregated β-sheet-rich structures in Parkinson's disease (PD) and Alzheimer's disease. The toxic oligomer hypothesis stipulates that prefibrillar assemblies, such as soluble oligomers or protofibrils, are responsible for the poor prognosis of these diseases. Previous studies demonstrated that a small molecule related to the natural compound orcein, O4, directly binds to amyloid-β fibrils and stabilizes them, accelerating the formation of end-stage mature fibrils. Here we demonstrate a similar phenomenon during O4 treatment of α-synuclein (αsyn) aggregates, the protein responsible for PD pathology. While the drug did not change the kinetics of aggregate formation as measured by the amyloidophilic dye thioflavin T, O4 depleted αsyn oligomers and promoted the formation of sodium dodecyl sulfate and proteinase K resistant aggregates consisting of large fibril clusters. These fibril clusters exhibited reduced toxicity to human neuronal model cells and reduced seeding activity in vitro. The effectiveness of O4 decreased when it was added at later points in the αsyn aggregation pathway, which suggests that the incorporation of O4 into fibril assemblies stabilizes them against chemical, enzymatic, and mechanic degradation. These findings suggest that small molecules, which stabilize amyloid fibrils, can prevent fibril fragmentation and seeding and consequently prevent prion-like replication of misfolded αsyn. Inhibiting prion replication by fibril stabilization could thus be a therapeutic strategy for PD.
Figures






Similar articles
-
Off-pathway oligomers of α-synuclein and Aβ inhibit secondary nucleation of α-synuclein amyloid fibrils.J Mol Biol. 2025 May 15;437(10):169048. doi: 10.1016/j.jmb.2025.169048. Epub 2025 Feb 25. J Mol Biol. 2025. PMID: 40015369
-
Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.Biochemistry. 2015 Aug 4;54(30):4599-610. doi: 10.1021/acs.biochem.5b00280. Epub 2015 Jul 24. Biochemistry. 2015. PMID: 26161848 Free PMC article.
-
Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2. Eur J Med Chem. 2016. PMID: 26974374 Review.
-
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9. J Neurosci. 2018. PMID: 30093536 Free PMC article.
-
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies.Cell Mol Life Sci. 2022 Mar 4;79(3):174. doi: 10.1007/s00018-022-04166-9. Cell Mol Life Sci. 2022. PMID: 35244787 Free PMC article. Review.
Cited by
-
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.J Neural Transm (Vienna). 2017 Jan;124(1):57-78. doi: 10.1007/s00702-016-1633-3. Epub 2016 Oct 28. J Neural Transm (Vienna). 2017. PMID: 27796511
-
Pyrogallol, Corilagin and Chebulagic acid target the "fuzzy coat" of alpha-synuclein to inhibit the fibrillization of the protein.RSC Adv. 2022 Dec 14;12(55):35770-35777. doi: 10.1039/d2ra04358k. eCollection 2022 Dec 12. RSC Adv. 2022. PMID: 36545068 Free PMC article.
-
The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.Neural Plast. 2017;2017:5012129. doi: 10.1155/2017/5012129. Epub 2017 Jan 3. Neural Plast. 2017. PMID: 28133550 Free PMC article. Review.
-
NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.Proc Natl Acad Sci U S A. 2021 May 4;118(18):e2017452118. doi: 10.1073/pnas.2017452118. Proc Natl Acad Sci U S A. 2021. PMID: 33903234 Free PMC article.
-
Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis.Acta Neuropathol. 2017 Jan;133(1):79-90. doi: 10.1007/s00401-016-1633-2. Epub 2016 Oct 18. Acta Neuropathol. 2017. PMID: 27757524 Free PMC article.
References
-
- Rao JN, Dua V, Ulmer TS. Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry. 2008;47:4651–4656. - PubMed
-
- Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous